Sandoz

À propos

Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people's lives. We contribute to society's ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1,000 molecules, covering all major therapeutic areas, accounted for 2017 sales of USD 10.1 billion. In 2017, our products reached well over 500 million patients. Sandoz is headquartered in Holzkirchen, in Germany's Greater Munich area. Sandoz is also on Twitter. Follow us on @Sandoz_global and Facebook: https://www.facebook.com/sandozglobal/ See the Sandoz community guidelines: https://www.sandoz.com/sites/www.sandoz.com/files/sandoz-social-media-community-guidelines.pdf